Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01523691 · ClinicalTrials.gov registry record · NA

Repeating Patterns of Sleep Restriction and Recovery

A NA study, sponsored by Beth Israel Deaconess Medical Center.

Completed
Registry status
NA
Development phase
17
Enrollment target

NCT01523691: Completed NA study, sponsored by Beth Israel Deaconess Medical Center.

NCT01523691 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01523691, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.

COMPLETED
Registry status
NA
Development phase
17 participants
Enrollment target

Study Summary

Goal of this study is to test the hypothesis that repeated exposure to cycles of insufficient sleep increases susceptibility to a variety of disease states by progressively compromising the integrity of stress response systems.

Primary Outcome

cortisol, ACTH, norepinephrine, IL-6, COX in blood/urine, among others

Interventions

  • BEHAVIORAL Repeated sleep restriction and recovery
  • BEHAVIORAL Control sleep

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2011-08
Est. Completion 2016-06
Phase NA

What the finished NCT01523691 record still lists

NCT01523691 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Repeated sleep restriction and recovery is the first listed.

NCT01523691 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01523691 about?

NCT01523691 is a clinical study titled "Repeating Patterns of Sleep Restriction and Recovery". Goal of this study is to test the hypothesis that repeated exposure to cycles of insufficient sleep increases susceptibility to a variety of disease states by progressively compromising the integrity of stress response systems.

What is the current status of trial NCT01523691?

This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2011-08. Estimated completion is 2016-06.

What interventions are being tested in trial NCT01523691?

The interventions under investigation include: Repeated sleep restriction and recovery (BEHAVIORAL), Control sleep (BEHAVIORAL).

Who is sponsoring clinical trial NCT01523691?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01523691's enrollment target sits among peer trials

17 1871st of 2000 higher than 130 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02090140 · 17 participants · NA

    Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects

  • NCT03317860 · 17 participants · NA

    Improving Measurement and Treatment of Post-stroke Neglect

  • NCT04356469 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children

  • NCT04414046 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01523691, the US trial registry maintained by the National Library of Medicine. NCT01523691 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.